📋 New blog from ABPI's Sophie Caseby unpacking the latest EFPIA W.A.I.T. Indicator report.
England ranks 7th in Europe for access to newly approved medicines overall — but 14th for cancer treatments.
What's driving the gap, and what needs to change? 👇
www.abpi.org.uk/media/blogs/...
NHS patients in England rank 7th in Europe for access to newly approved medicines, according to the latest EFPIA W.A.I.T. Indicator report — but significant gaps remain, particularly for cancer and ra...
